SEC Probes Drug Trial Firm Accused Of Recklessness
The problems facing drug-testing firm SFBC International expanded this week when the Securities and Exchange Commission issued an informal request for documents related to two executives who recently left the company....To view the full article, register now.
Already a subscriber? Click here to view full article